180 related articles for article (PubMed ID: 27498064)
1. Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism.
Kadlub N; Sessiecq Q; Dainese L; Joly A; Lehalle D; Marlin S; Badoual C; Galmiche L; Majoufre-Lefebvre C; Berdal A; Deckert M; Vazquez MP; Descroix V; Coudert AE; Picard A
Hum Pathol; 2016 Dec; 58():62-71. PubMed ID: 27498064
[TBL] [Abstract][Full Text] [Related]
2. NFATc1 and TNFalpha expression in giant cell lesions of the jaws.
Amaral FR; Brito JA; Perdigão PF; Carvalho VM; de Souza PE; Gomez MV; De Marco L; Gomez RS
J Oral Pathol Med; 2010 Mar; 39(3):269-74. PubMed ID: 20002873
[TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation.
Kadlub N; Sessiecq Q; Mandavit M; L'Hermine AC; Badoual C; Galmiche L; Berdal A; Descroix V; Picard A; Coudert AE
Orphanet J Rare Dis; 2018 Sep; 13(1):166. PubMed ID: 30236129
[TBL] [Abstract][Full Text] [Related]
4. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism.
Kadlub N; Vazquez MP; Galmiche L; L'Herminé AC; Dainese L; Ulinski T; Fauroux B; Pavlov I; Badoual C; Marlin S; Deckert M; Leboulanger N; Berdal A; Descroix V; Picard A; Coudert AE
J Bone Miner Res; 2015 May; 30(5):878-85. PubMed ID: 25491283
[TBL] [Abstract][Full Text] [Related]
5. SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism.
Lietman SA; Prescott NL; Hicks DG; Westra WH; Levine MA
Clin Orthop Relat Res; 2007 Jun; 459():22-7. PubMed ID: 17545756
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic study of 24 cases of cherubism.
Meng XM; Yu SF; Yu GY
Int J Oral Maxillofac Surg; 2005 Jun; 34(4):350-6. PubMed ID: 16053841
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the SH3BP2 gene mutation in cherubism.
Lee JY; Jung YS; Kim SA; Lee SH; Ahn SG; Yoon JH
Acta Med Okayama; 2008 Jun; 62(3):209-12. PubMed ID: 18596838
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-Src and comparison of cytologic features in cherubism, central giant cell granuloma and giant cell tumors.
Wang C; Song Y; Peng B; Fan M; Li J; Zhu S; Bian Z
Oncol Rep; 2006 Mar; 15(3):589-94. PubMed ID: 16465417
[TBL] [Abstract][Full Text] [Related]
9. SH3BP2 is an activator of NFAT activity and osteoclastogenesis.
Lietman SA; Yin L; Levine MA
Biochem Biophys Res Commun; 2008 Jul; 371(4):644-8. PubMed ID: 18440306
[TBL] [Abstract][Full Text] [Related]
10. Uterine leiomyosarcomas with osteoclast-like giant cells associated with high expression of RUNX2 and RANKL.
Terasaki M; Terasaki Y; Wakamatsu K; Kuwahara N; Yoneyama K; Kawase R; Kurose K; Toda E; Endo Y; Kunugi S; Kajimoto Y; Shimizu A
Virchows Arch; 2021 May; 478(5):893-904. PubMed ID: 33404854
[TBL] [Abstract][Full Text] [Related]
11. Cherubism: best clinical practice.
Papadaki ME; Lietman SA; Levine MA; Olsen BR; Kaban LB; Reichenberger EJ
Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S6. PubMed ID: 22640403
[TBL] [Abstract][Full Text] [Related]
12. A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in a case of nonfamilial cherubism.
Imai Y; Kanno K; Moriya T; Kayano S; Seino H; Matsubara Y; Yamada A
Cleft Palate Craniofac J; 2003 Nov; 40(6):632-8. PubMed ID: 14577811
[TBL] [Abstract][Full Text] [Related]
13. SH3BP2 mutations potentiate osteoclastogenesis via PLCγ.
Lietman SA; Yin L; Levine MA
J Orthop Res; 2010 Nov; 28(11):1425-30. PubMed ID: 20872577
[TBL] [Abstract][Full Text] [Related]
14. Fine-needle aspiration cytological features of Cherubism.
Jing X; Pu RT
Diagn Cytopathol; 2008 Mar; 36(3):188-9. PubMed ID: 18232001
[TBL] [Abstract][Full Text] [Related]
15. Fine needle aspiration cytologic features of Cherubism: a case report.
Gupta N; Duggal R; Rajwanshi A; Rattan V
Acta Cytol; 2010; 54(4):595-7. PubMed ID: 20715662
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a Norwegian cherubism cohort; molecular genetic findings, oral manifestations and quality of life.
Prescott T; Redfors M; Rustad CF; Eiklid KL; Geirdal AØ; Storhaug K; Jensen JL
Eur J Med Genet; 2013 Mar; 56(3):131-7. PubMed ID: 23298620
[TBL] [Abstract][Full Text] [Related]
17. Cherubism: clinicopathologic features.
Yamaguchi T; Dorfman HD; Eisig S
Skeletal Radiol; 1999 Jun; 28(6):350-3. PubMed ID: 10450884
[TBL] [Abstract][Full Text] [Related]
18. Computer-assisted analysis of immunohistological parameters in oral giant cell granulomas.
Yoon JH; Li M; Basile JR; Lin YL
Oral Dis; 2019 Apr; 25(3):796-802. PubMed ID: 30565380
[TBL] [Abstract][Full Text] [Related]
19. Cherubism: a clinical, radiographic, and histopathologic comparison of 7 cases.
Peñarrocha M; Bonet J; Mínguez JM; Bagán JV; Vera F; Mínguez I
J Oral Maxillofac Surg; 2006 Jun; 64(6):924-30. PubMed ID: 16713807
[TBL] [Abstract][Full Text] [Related]
20. [Bilateral giant cell central granuloma of the jaws in a Noonan syndrome: About one case with emphasizing on bone giant cell lesions of the jaws].
Sizaret D; Tallegas M; de Pinieux G
Ann Pathol; 2022 Apr; 42(3):259-263. PubMed ID: 35058088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]